Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M368Revenue $M89.6Net Margin (%)6.2Z-Score4.3
Enterprise Value $M350EPS $0.2Operating Margin %8.8F-Score4
P/E(ttm))58.9Cash Flow Per Share $-0.5Pre-tax Margin (%)7.9Higher ROA y-yN
Price/Book5.310-y EBITDA Growth Rate %0Quick Ratio2.8Cash flow > EarningsN
Price/Sales3.95-y EBITDA Growth Rate %0Current Ratio2.8Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %-58.2ROA % (ttm)4.2Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)9.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M44.3ROI % (ttm)9.1Gross Margin Increase y-yN

Gurus Latest Trades with SCMP

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

SCMP is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


SCMP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Kuno Sachiko10% Owner 2014-08-07Sell181,727$6.2834.08 view
Ueno Ryuji10% Owner 2014-08-07Sell181,727$6.2834.08 view
S&R Technology Holdings, LLC10% Owner 2014-08-07Sell181,727$6.2834.08 view
Ueno Ryuji10% Owner 2014-08-04Sell140,873$6.0239.87 view
S&R Technology Holdings, LLC10% Owner 2014-08-04Sell140,873$6.0239.87 view
Kuno Sachiko10% Owner 2014-08-04Sell140,873$6.0239.87 view
S&R Technology Holdings, LLC10% Owner 2014-07-31Sell400$6.2534.72 view
Kuno Sachiko10% Owner 2014-07-31Sell400$6.2534.72 view
Ueno Ryuji10% Owner 2014-07-31Sell400$6.2534.72 view
Ueno Ryuji10% Owner 2014-07-25Sell16,155$6.2634.5 view

Press Releases about SCMP :

    Quarterly/Annual Reports about SCMP:

    News about SCMP:

    Articles On GuruFocus.com
    Weekly CEO Sells Highlight: VeriFone Systems Inc, Northeast Utilities, Sucampo Pharmaceuticals Inc, Jan 26 2014 
    Weekly CEO Sells Highlight: Sucampo Pharmaceuticals Inc, Family Dollar Stores Inc, Nike Inc, Hallibu Oct 21 2013 
    comment on SCMP Mar 06 2013 
    Sucampo Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 08 2011 
    Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 03 2010 
    Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 05 2010 
    Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) May 10 2010 
    Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 06 2009 
    Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 07 2009 
    Sucampo Pharmaceuticals Reports Financial Results for the Second Quarter of 2009 Aug 06 2009 

    More From Other Websites
    Sucampo Solidifies Leadership Team With Additions of CSO and Heads of Business Development,... Oct 23 2014
    SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers,... Oct 23 2014
    Sucampo Solidifies Leadership Team With Additions of CSO and Heads of Business Development,... Oct 23 2014
    SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other... Oct 22 2014
    Takeda and Sucampo Enter Into Global Licensing Agreement for AMITIZA(R) (lubiprostone) Oct 21 2014
    6:04 pm Sucampo Pharma and Takeda (TKPYY) enter into global... Oct 21 2014
    Takeda and Sucampo Enter Into Global Licensing Agreement for AMITIZA(R) (lubiprostone) Oct 21 2014
    Sucampo/Takeda Amend Collaboration Agreement for Amitiza Oct 15 2014
    SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other... Oct 14 2014
    Sucampo Announces Extension of AMITIZA(R) (lubiprostone) License and Collaboration Agreement With... Oct 14 2014
    Sucampo Enters into Settlement Agreement for Amitiza Oct 13 2014
    Strength Seen in Sucampo (SCMP): Stock Rises 9.4% Oct 13 2014
    Clinical Data for AMITIZA(R) Lubiprostone to be Presented at the American College of... Oct 13 2014
    SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events Oct 10 2014
    Vertex Pharmaceuticals (VRTX) Updates on Kalydeco Studies Oct 10 2014
    Sucampo Pharma upgraded by Maxim Group Oct 10 2014
    R-Tech Ueno: Settlement Agreement That Resolves Patent Litigation in U.S. Related to AMITIZA® and... Oct 10 2014
    SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other... Oct 09 2014
    Sucampo Announces Settlement Agreement That Resolves Patent Litigation in U.S. Related to AMITIZA Oct 09 2014
    Novartis Collaborates with Bristol-Myers Squibb Oct 07 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK